8/29/25 16:19  | 8/27/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.m | -6,353 | 28.23 | 0 | -225 | -12 | 1,646 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/18/25 16:02  | 7/17/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -399 | 20.21 | 0 | -20 | -1 | 1,871 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/16/25 16:11  | 7/14/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.dm | -2,813 | 20.19 | 0 | -139 | -7 | 1,882 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/30/25 12:03  | 1/29/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -83 | 29.52 | 0 | -3 | 0 | 1,955 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/25 15:28  | 1/22/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -412 | 30.43 | 0 | -14 | -1 | 1,958 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/21/25 16:04  | 1/17/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -180 | 29.96 | 0 | -6 | 0 | 1,971 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/14/25 16:18  | 1/13/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -179 | 28.70 | 0 | -6 | 0 | 1,847 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/5/24 16:07  | 3/1/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -16,029 | 64.11 | 0 | -250 | -11 | 2,035 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 16:49  | 2/12/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -268 | 67.77 | 0 | -4 | 0 | 2,035 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/24 16:26  | 1/29/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -182 | 64.14 | 0 | -3 | 0 | 2,039 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/24 19:28  | 1/22/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -873 | 65.00 | 0 | -13 | -1 | 2,042 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/17/24 16:32  | 1/16/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -525 | 66.81 | 0 | -8 | 0 | 2,055 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/21/23 17:36  | 11/21/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S | -244 | 48.80 | 0 | -5 | 0 | 1,991 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/1/23 16:05  | 9/1/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -6,263 | 41.75 | 0 | -150 | -7 | 1,996 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/23 17:10  | 5/16/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -2,570 | 85.66 | 0 | -30 | -2 | 1,846 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/23 16:51  | 4/18/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -2,461 | 82.02 | 0 | -30 | -2 | 1,826 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/23/23 16:55  | 3/21/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Francois Cedric | MA | DO | CEO | S.d | -1,882 | 62.74 | 0 | -30 | -2 | 1,806 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |